therapeutic capacity of apoptotic mononuclear cell
play

Therapeutic Capacity of Apoptotic Mononuclear Cell Secretome in - PowerPoint PPT Presentation

Therapeutic Capacity of Apoptotic Mononuclear Cell Secretome in Experimental Spinal Cord Injury Doctoral viva Thomas Haider, M.D. CHRISTIAN DOPPLER LABORATORY for the Diagnosis & Regeneration of Cardiac and Thoracic Diseases Medical


  1. Therapeutic Capacity of Apoptotic Mononuclear Cell Secretome in Experimental Spinal Cord Injury Doctoral viva Thomas Haider, M.D. CHRISTIAN DOPPLER LABORATORY for the Diagnosis & Regeneration of Cardiac and Thoracic Diseases Medical University of Vienna www.meduniwien.ac.at/applied-immunology Vienna, March 29, 2016 Medical University of Vienna Haider T

  2. Introduction Stem Cell Therapy J Clin Neurol 2016;12(1):14-20 Medical University of Vienna Haider T

  3. Introduction J Clin Neurol 2016;12(1):14-20 Medical University of Vienna Haider T

  4. Introduction Nat. Rev. Cardiol. 2010; 7: 204-215. Medical University of Vienna Haider T

  5. Introduction Myocardial Infarc.on The Dying Stem Cell Hypothesis by Anker et al. up to 25% of all transplanted cells are in the state of apoptosis apoptotic cells induce transient immunosuppression Necrosis A3rac.on of immune cells Secre.on of pro-inflammatory cytokines IL-1 IL-6 TNF-α Amplifica.on of inflamma.on J Am Coll Cardiol. 2005 Nov 15;46(10):1799-802. J Clin Invest. 2001 Oct;108(7):957-62. Medical University of Vienna Haider T

  6. Introduction Stem Cell Engraftment and Transdifferentiation? Low number of transplanted cells • Permanent engraftment not observable • Therapeutic effect in less than 72h • Secretome (CM) alone delivers comparable results • Circ Res. 2008 Nov 21; 103(11): 1204–1219. Medical University of Vienna Haider T

  7. Introduction Stem Cells InternaIonal, Volume 2015, ArIcle ID 765846 Medical University of Vienna Haider T

  8. Introduction Comparability of BMCs and PBMCs Secretome Secretome: Difference in 35 out of 174 analyzed factors • • 25 secreted factors were higher in BMC-secretome • 10 secreted factors were higher in PBMC-secretome European Heart Journal (2008) 29, 2851–2858 . Medical University of Vienna Haider T

  9. Introduction Centrifuga.on Lyophiliza.on Suspensions of control apopto.c PBMC Eur J Clin Invest. 2009 Jun;39(6):445-56. Irradiated cultured apopto.c peripheral blood mononuclear cells regenerate infarcted myocardium.

  10. Introduction Attenuation of acute myocardial infarction • (Lichtenauer et al; Basic Res Cardiol. 2011) Medical University of Vienna Haider T

  11. Introduction Attenuation of acute myocardial infarction • (Lichtenauer et al; Basic Res Cardiol. 2011) Immunosuppression in an experimental myocarditis model • (Hoetzencker et al; Eur Heart J. 2013) Medical University of Vienna Haider T

  12. Introduction Attenuation of acute myocardial infarction • (Lichtenauer et al; Basic Res Cardiol. 2011) Immunosuppression in an experimental myocarditis model • (Hoetzencker et al; Eur Heart J. 2013) Inhibition of MVO and thrombocyte activation • (Hoetzencker et al; Bas Res Cardiol 2012) Medical University of Vienna Haider T

  13. Introduction Attenuation of acute myocardial infarction • (Lichtenauer et al; Basic Res Cardiol. 2011) Immunosuppression in an experimental myocarditis model • (Hoetzencker et al; Eur Heart J. 2013) Inhibition of MVO and thrombocyte activation • (Hoetzencker et al; Bas Res Cardiol 2012) Wound healing in a murine and porcine wound model • (Mildner et al; PLoS One. 2013) Medical University of Vienna Haider T

  14. Introduction Attenuation of acute myocardial infarction • (Lichtenauer et al; Basic Res Cardiol. 2011) Immunosuppression in an experimental myocarditis model • (Hoetzencker et al; Eur Heart J. 2013) Inhibition of MVO and thrombocyte activation • (Hoetzencker et al; Bas Res Cardiol 2012) Wound healing in a murine and porcine wound model • (Mildner et al; PLoS One. 2013) Experimental stroke model • (Altmann et al; F1000Res. 2014 Jun 19 [revised 2014 Oct 28]) Medical University of Vienna Haider T

  15. Introduction Altmann et al., F1000Res. 2014 Jun 19 Medical University of Vienna Haider T

  16. Introduction Altmann et al., F1000Res. 2014 Jun 19 Medical University of Vienna Haider T

  17. Introduction Induction of Apoptosis non-irradiated irradiated 1.5 [Relative expression] ** γ -IR - - + + 1.0 HLF HLF 0.5 0.0 γ -IR - + 20h Beer et al. BMC Genomics 2014 Medical University of Vienna Haider T

  18. Introduction 2,5*10^6 IL-8 (pg/ml) 2305,8 ±136,4 GRO-alpha (pg/ml) 487,7 ±89,5 Compounds of the Secretome ENA-78 (pg/ml) 37857,5 ±12734,2 MCP-1 (pg/ml) 739,9 ±175,5 CD40 pos C5a G-CSF GM-CSF GRO- α CCL1 sICAM-1 IFN- γ pos NAP-2 (µg/ml) 9,9 ±0,5 ligand RANTES (pg/ml) 22251,2 ±3641,9 IL-4 IL-5 IL-6 IL-1 α IL-1 β IL-1ra IL-2 IL-8 sICAM-1 (pg/ml) 2068,2 ±415,2 IL-10 IL-12 p70 IL-13 IL-16 IL-17 IL-17E IL-23 IL-27 IL-32 α CXCL10 CXCL11 MCP-1 MIF MIP-1 α MIP-1 β PAI- VEGF 165 (pg/ml) 640,1 ±35,2 1 pos SDF-1 TNF- α sTREM-1 IL-16 (pg/ml) 1254,2 ±77,6 RANTES neg IL-1ra (pg/ml) 410,7 ±167,0 IL-10 (pg/ml) 7,1 ±0,5 pos Activin A ADAMTS-1 Angi Angiopoieti Angiopoieti Plas Amphir Artem pos IGF-I (pg/ml) 5,8 ±3,2 ogeni n-1 n-2 mino egulin in n gen EGF EG- CD10 Endo Endotheli FGF FGF- TF CXCL16 CD26 FGF FGF- HGF (pg/ml) 72,9 ±19,1 VEGF 5 statin n-1 acidi 7 basic 4 c Lepti MCP GDN GM- HB- HGF IGFBP IGFBP IGFBP- IL-1 β IL-8 TGF- n -1 FGF-2 (pg/ml) 534,2 ±11,6 F CSF EGF -1 -2 3 β 1 MM MM NRG Pentr MIP-1 PD- PDG PDG Perse CXC Prola CXC P-8 P-9 1- β 1 axin a ECG F-AA F- phin L4 ctin L4 TGF-beta (pg/ml) 87,3 ±20,4 3 F AB/ Vaso VEG Serpi PAI- Serpi TIM TIM TSP- TSP- uPA VEG BB hibin F-C n B5 1 n F1 P-1 P-4 1 2 F MMP9 (pg/ml) 3612,3 ±597,7 pos neg MIF (pg/ml) 20147,5 ±1140,2 PAI-1 (pg/ml) 5060,6 ±3247,5 Lichtenauer et. Al Basic Res Cardiol. 2011 Nov;106(6):1283-97. SDF-1 (pg/ml) 148,5 ±7,1 Medical University of Vienna Haider T

  19. Introduction Compounds of the Secretome Secreted Proteins • Oxidized Lipids • Extracellular vesicles • • Microparticles • Exosomes Beer et al. BMC Genomics 2014 Medical University of Vienna Haider T

  20. Introduction Spinal Cord Injury Medical University of Vienna Haider T

  21. Introduction www.schweizer-illustrierte.ch Spinal Cord Injury www.wikipedia.com 50 per 1 million annually worldwide (200/year in AUT) • Average age of patients : 31 years • 50% experience total loss of motor function • www.web.de 2 out of 3 – cervical spinal cord affected • J Neurosurg. 1991; 75(1): 15-26. J Neurotrauma. 2004; 21(10): 1355-70. Medical University of Vienna Haider T

  22. Introduction Spinal Cord Injury The Spine Journal 2004; 4(4): 451-64. Medical University of Vienna Haider T

  23. Introduction Spinal Cord Injury – Treatment Early surgical decompression • Corticosteroids (?) – Methylprednisolone (MP) regime • Rehabilitation • J Neurotrauma 2011; 28: 1371-1399 Medical University of Vienna Haider T

  24. Introduction Spinal Cord Injury – Treatment 30 years of SCI research -> 1 approved treatment option (MP) • aside from surgical therapy Recommendation for the use of MP in SCI was revoked in 2013 • by the AANS J Neurotrauma 2011; 28: 1371-1399 Medical University of Vienna Haider T

  25. Introduction The Spine Journal 2004; 4(4): 451-64. Medical University of Vienna Haider T

  26. Introduction Front. Cell. Neurosci. 2013; 4. Medical University of Vienna Haider T

  27. Hypothesis Compounds of secretome of apoptotic peripheral blood mononuclear cells exert therapeutic capacity Medical University of Vienna Haider T

  28. Methods Infinite Horizon Impactor Contusion Injury Model BBB-Score J Neurotrauma. 2003; 20(2): 179-93. J Neurotrauma. 1995; 12(1): 1-21. Medical University of Vienna Haider T

  29. Methods Incuba.on for 24h Cell Separa.on Irradia.on Venous Blood Withdrawal Centrifuga.on Lyophiliza.on Lyophilized MNC-secretomes Virus Elimina.on (GMP) Medical University of Vienna Haider T

  30. Methods Exp Neurol. 2015; 267: 230-242. Medical University of Vienna Haider T

  31. -RESULTS- Medical University of Vienna Haider T

  32. Results Exp Neurol. 2015; 267: 230-242. Medical University of Vienna Haider T

  33. Results Exp Neurol. 2015; 267: 230-242. Medical University of Vienna Haider T

  34. Results A B n=4 Exp Neurol. 2015; 267: 230-242. Medical University of Vienna Haider T

  35. Results n=4 Exp Neurol. 2015; 267: 230-242. Medical University of Vienna Haider T

  36. Results n=3 Exp Neurol. 2015; 267: 230-242. Medical University of Vienna Haider T

  37. Results n=3 Exp Neurol. 2015; 267: 230-242. Medical University of Vienna Haider T

  38. Results Exp Neurol. 2015; 267: 230-242. Medical University of Vienna Haider T

  39. Results Exp Neurol. 2015; 267: 230-242. Medical University of Vienna Haider T

  40. Previous Results Basic Res Cardiol. 2011 Jun;106(4):645-55. Medical University of Vienna Haider T

  41. Results Exp Neurol. 2015; 267: 230-242. Medical University of Vienna Haider T

  42. Results n=3 Exp Neurol. 2015; 267: 230-242. Beer et al. BMC Genomics 2014. Medical University of Vienna Haider T

  43. Results Exp Neurol. 2015; 267: 230-242. Medical University of Vienna Haider T

Recommend


More recommend